Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Neuropharmacology|April 1, 1990
The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbensJ M Barnes, N M Barnes, B Costall, et al.
The Annals of Pharmacotherapy|October 1, 1996
Barriers to compliance with OBRA'90 regulations in community pharmaciesJ M Barnes, J E Riedlinger, W W McCloskey, et al.
British Journal of Cancer|February 1, 1989
Prognostic relevance of DNA content in childhood renal tumoursS Kumar, H B Marsden, R A Cowan, et al.
European Journal of Pharmacology|January 19, 1993
Identification and characterisation of angiotensin II receptor subtypes in human brainJ M Barnes, L J Steward, P C Barber, et al.
Vital and Health Statistics. Ser. 4, Documents and Committee Reports|June 1, 1991
The 1989 revision of the U.S. Standard Certificates and ReportsG C Tolson, J M Barnes, G A Gay, et al.
Pharmacopsychiatry|February 1, 1990
Biochemical models for cognition enhancersB Costall, J M Barnes, M Hamon, et al.
Pediatric Nephrology (Berlin, Germany)|April 1, 1988
Glomerular basement membrane thickness in children. A morphometric studyM Morita, R H White, F Raafat, et al.
Neuropharmacology|November 1, 1990
Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the ratJ M Barnes, N M Barnes, S Champaneria, et al.
Neuropharmacology|August 1, 1988
Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferretJ M Barnes, N M Barnes, B Costall, et al.
Nature|April 27, 1989
5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueJ M Barnes, N M Barnes, B Costall, et al.
Pageof 10